Get the Stockscreener App
3.18
0.00%
0.00
After Hours:
3.18
Macrogenics Inc Stock (MGNX) Forecast
The Macrogenics Inc (MGNX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $7.8784, representing a +147.75% increase from the current price of $3.18. The highest analyst price target is $9.509, and the lowest is $6.2478.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MGNX Price Target
Average 16.40
(+415.80% Upside)
Is Macrogenics Inc (MGNX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 40.37 | Neutral |
| STOCH(9,6) | 17.49 | Buy |
| STOCHRSI(14) | 10.70 | Buy |
| MACD(12,26) | -0.1153 | Sell |
| ADX(14) | 9.6757 | Neutral |
| William %R | -86.21 | Buy |
| CCI(14) | -106.87 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.297
Sell
|
3.2848
Sell
|
| MA20 |
3.382
Sell
|
3.3785
Sell
|
| MA50 |
3.6472
Sell
|
3.5484
Sell
|
| MA100 |
3.5473
Sell
|
4.1127
Sell
|
| MA200 |
6.5457
Sell
|
5.2648
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, MGNX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on MGNX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 40.37 indicates that MGNX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 17.49 indicates that MGNX is oversold. This indicates that MGNX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 10.7 indicates that MGNX is oversold. This suggests that MGNX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 9.6757 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -106.87 indicates that MGNX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term MGNX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Macrogenics Inc financial reports and earnings history, Macrogenics Inc (MGNX) stock could reach $15.76 by 2030, $2.8944 by 2040 and $1.7742 by 2050. See the projected annual prices until 2050 of the Macrogenics Inc stock below:
- Macrogenics Inc (MGNX) is expected to reach an average price of $4.3327 in 2035, with a high prediction of $4.8027 and a low estimate of $1.8279. This indicates an $36.25% rise from the last recorded price of $3.18.
- Macrogenics Inc (MGNX) stock is projected to chart a bullish course in 2040, with an average price target of $2.0782, representing an $-34.65% surge from its current level. The forecast ranges from a conservative $1.3696 to a sky-high $2.8944.
- Our analysts predict Macrogenics Inc (MGNX) to jump -6.46% by 2045, soaring from $3.1446 to an average price of $2.9746, potentially reaching $3.0244. While $3.1446 is the low estimate, the potential upside is significant.
- Macrogenics Inc (MGNX) stock is expected to climb by 2050, reaching an average of $1.0932, a $-65.62% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1.7742 and $0.0698, respectively, highlighting the market's uncertainty.
Macrogenics Inc Stock (MGNX) Year by Year Forecast
Macrogenics Inc Stock (MGNX) Price Forecast for 2025
Macrogenics Inc Stock (MGNX) is expected to reach an average price of $16.40 in 2025, with a high prediction of $30.48 and a low estimate of $2.3268. This indicates an +415.80% rise from the last recorded price of $3.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $9.2152 | $6.2478 | $9.509 | +189.79% |
| February, 2025 | $7.5126 | $7.4526 | $10.78 | +136.24% |
| March, 2025 | $6.81 | $6.8078 | $10.83 | +114.15% |
| April, 2025 | $3.958 | $2.3268 | $7.6556 | +24.46% |
| May, 2025 | $5.2703 | $3.2898 | $5.6103 | +65.73% |
| June, 2025 | $24.09 | $4.8021 | $27.78 | +657.63% |
| July, 2025 | $27.07 | $16.72 | $27.86 | +751.12% |
| August, 2025 | $28.82 | $23.87 | $30.48 | +806.23% |
| September, 2025 | $25.72 | $22.25 | $29.64 | +708.82% |
| October, 2025 | $24.76 | $22.87 | $27.66 | +678.73% |
| November, 2025 | $23.50 | $22.11 | $30.31 | +638.86% |
| December, 2025 | $17.72 | $17.21 | $25.27 | +457.20% |
Macrogenics Inc Stock (MGNX) Price Forecast for 2026
The predicted value for Macrogenics Inc (MGNX) in 2026 is set at an average of $25.64. Estimates vary from a peak of $34.81 to a trough of $16.48, indicating an +706.38% surge from the present price of $3.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $21.38 | $16.99 | $21.86 | +572.37% |
| February, 2026 | $23.61 | $19.39 | $26.50 | +642.57% |
| March, 2026 | $18.91 | $18.44 | $24.90 | +494.53% |
| April, 2026 | $18.32 | $17.20 | $22.43 | +476.07% |
| May, 2026 | $28.79 | $16.48 | $29.81 | +805.39% |
| June, 2026 | $29.48 | $27.10 | $31.93 | +827.16% |
| July, 2026 | $27.82 | $26.31 | $34.81 | +774.74% |
| August, 2026 | $19.66 | $19.54 | $31.14 | +518.21% |
| September, 2026 | $26.27 | $18.63 | $27.49 | +726.17% |
| October, 2026 | $22.88 | $22.04 | $26.52 | +619.64% |
| November, 2026 | $21.95 | $19.59 | $23.27 | +590.16% |
| December, 2026 | $19.30 | $17.45 | $26.43 | +506.92% |
Macrogenics Inc Stock (MGNX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Macrogenics Inc (MGNX) is $10.76, with a high forecast of $21.02 and a low forecast of $0.4956. This indicates an +238.35% increase from the last price of $3.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $17.43 | $17.32 | $20.12 | +448.19% |
| February, 2027 | $16.89 | $15.63 | $21.02 | +431.28% |
| March, 2027 | $14.92 | $14.07 | $18.08 | +369.11% |
| April, 2027 | $12.79 | $11.85 | $16.01 | +302.20% |
| May, 2027 | $9.9125 | $9.2825 | $12.51 | +211.71% |
| June, 2027 | $6.6054 | $6.4854 | $10.67 | +107.72% |
| July, 2027 | $7.1678 | $6.2666 | $7.7272 | +125.40% |
| August, 2027 | $6.1702 | $6.0002 | $8.559 | +94.03% |
| September, 2027 | $1.8632 | $1.6332 | $6.6608 | -41.41% |
| October, 2027 | $0.6656 | $0.4956 | $2.0238 | -79.07% |
| November, 2027 | $1.868 | $0.8162 | $1.998 | -41.26% |
| December, 2027 | $3.591 | $1.3286 | $3.781 | +12.92% |
Macrogenics Inc Stock (MGNX) Price Forecast for 2028
In 2028, Macrogenics Inc (MGNX) is projected to reach an average price of $3.8035, with a high projection of $6.2973 and a low estimate of $1.3097. This indicates an +19.61% rise from the last price of $3.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.6134 | $2.0522 | $3.6316 | -17.82% |
| February, 2028 | $1.8358 | $1.3097 | $2.689 | -42.27% |
| March, 2028 | $3.4987 | $1.5219 | $3.6187 | +10.02% |
| April, 2028 | $4.3011 | $3.0793 | $5.9505 | +35.26% |
| May, 2028 | $4.3241 | $3.9241 | $5.6023 | +35.98% |
| June, 2028 | $4.1765 | $3.1515 | $5.3853 | +31.34% |
| July, 2028 | $3.8989 | $3.8583 | $4.8471 | +22.61% |
| August, 2028 | $3.7119 | $2.9195 | $5.5801 | +16.73% |
| September, 2028 | $5.7343 | $4.0225 | $6.1059 | +80.32% |
| October, 2028 | $5.5067 | $4.5799 | $5.9367 | +73.17% |
| November, 2028 | $3.2596 | $2.9591 | $6.2973 | +2.50% |
| December, 2028 | $3.752 | $3.2202 | $4.5808 | +17.99% |
Macrogenics Inc Stock (MGNX) Price Forecast for 2029
The 2029 price forecast for Macrogenics Inc Stock (MGNX) is $11.50 on average, with a high prediction of $20.31 and a low estimate of $2.7016. This represents an +261.77% increase from the previous price of $3.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.175 | $2.8444 | $3.8526 | -0.16% |
| February, 2029 | $3.4574 | $3.0156 | $4.8562 | +8.72% |
| March, 2029 | $3.0698 | $3.0498 | $3.9098 | -3.47% |
| April, 2029 | $3.4822 | $2.7016 | $3.5572 | +9.50% |
| May, 2029 | $4.8152 | $2.9078 | $5.7552 | +51.42% |
| June, 2029 | $6.7976 | $4.5558 | $6.8176 | +113.76% |
| July, 2029 | $8.0399 | $6.6182 | $9.1558 | +152.83% |
| August, 2029 | $12.72 | $7.7505 | $13.19 | +300.09% |
| September, 2029 | $16.57 | $12.49 | $17.27 | +420.92% |
| October, 2029 | $12.91 | $12.90 | $20.31 | +305.92% |
| November, 2029 | $14.04 | $11.25 | $17.97 | +341.53% |
| December, 2029 | $13.81 | $12.56 | $15.16 | +334.20% |
Macrogenics Inc Stock (MGNX) Price Forecast for 2030
Macrogenics Inc Stock (MGNX) is expected to reach an average price of $8.1855 in 2030, with a high forecast of $15.76 and a low forecast of $0.6135. This signifies an +157.40% surge from the last price of $3.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11.82 | $10.64 | $15.76 | +271.73% |
| February, 2030 | $12.42 | $11.36 | $14.00 | +290.43% |
| March, 2030 | $10.52 | $9.8781 | $12.53 | +230.83% |
| April, 2030 | $10.87 | $9.5817 | $12.00 | +241.68% |
| May, 2030 | $9.3484 | $8.8731 | $11.19 | +193.97% |
| June, 2030 | $5.3611 | $5.2361 | $9.6725 | +68.59% |
| July, 2030 | $5.172 | $3.977 | $5.6373 | +62.64% |
| August, 2030 | $7.4268 | $4.5256 | $7.6668 | +133.55% |
| September, 2030 | $7.5616 | $6.9192 | $8.2016 | +137.79% |
| October, 2030 | $6.8076 | $5.7352 | $9.064 | +114.07% |
| November, 2030 | $2.3123 | $1.2323 | $9.1199 | -27.29% |
| December, 2030 | $1.7771 | $0.6135 | $2.7647 | -44.12% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):